Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans

Maris R. Davis, Harry Shamoon

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Insulin-mediated glucose disposal was studied immediately prior to and following moderate hypoglycemia in nondiabetic subjects and subjects with insulin-dependent (type I) diabetes mellitus (IDDM), the latter having varying epinephrine secretory capacities. Plasma insulin concentration was fixed throughout the study at ∼300 to 400 pmol/L to avoid effects of waning insulin action and plasma glucose was clamped at either 5 mmol/L (euglycemic control) or at 3.1 mmol/L (hypoglycemic) periods of 120 minutes. Baseline (clamp 1) and postexperiment (clamp 2) periods were assessed for net glucose disposal (as a function of the exogenous glucose infusion rate) and glucose kinetics using 3H-glucose. In normal subjects, glucose disposal increased progressively by 132% during control studies but only by 57% with intervening hypoglycemia (P < .005). Similarly, subjects with IDDM displayed marked reduction in glucose disposal following hypoglycemia (152% increment during control v 33% during hypoglycemia, P < .025). These changes were mediated by reduction of whole-body glucose uptake (rate of glucose disappearance [Rd], [3H]-3-glucose) and metabolic clearance rates with comparable suppression of hepatic glucose production in both groups. The increase in plasma free-fatty acids (FFA) following hypoglycemia was modest but greater in subjects with IDDM (P < .01), whereas IDDM had reduced concentrations of epinephrine (P < .01) and glucagon (P < .005) during hypoglycemia. In subjects with IDDM but not in normal subjects, the change in posthypoglycemia glucose disposal was inversely correlated with the increase in plasma norepinephrine (R2 = .54, P < .004) and epinephrine (R2 = .32, P < .04). Glucose disposal did not correlate with other counterregulatory hormones, plasma FFA, or antecedent glycemic control. The data suggest that posthypoglycemic insulin resistance develops immediately following mild hypoglycemia in humans. Impaired glucose disposal occurs in IDDM despite reduced epinephrine secretory responses and correlates with parameters of neuroadrenergic function.

Original languageEnglish (US)
Pages (from-to)216-223
Number of pages8
JournalMetabolism
Volume41
Issue number2
DOIs
StatePublished - 1992

Fingerprint

Hypoglycemia
Glucose
Type 1 Diabetes Mellitus
Epinephrine
Insulin
Nonesterified Fatty Acids
Metabolic Clearance Rate
Glucagon
Hypoglycemic Agents
Insulin Resistance
Norepinephrine

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans. / Davis, Maris R.; Shamoon, Harry.

In: Metabolism, Vol. 41, No. 2, 1992, p. 216-223.

Research output: Contribution to journalArticle

@article{e44b129d25234692802fa16d0637f33f,
title = "Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans",
abstract = "Insulin-mediated glucose disposal was studied immediately prior to and following moderate hypoglycemia in nondiabetic subjects and subjects with insulin-dependent (type I) diabetes mellitus (IDDM), the latter having varying epinephrine secretory capacities. Plasma insulin concentration was fixed throughout the study at ∼300 to 400 pmol/L to avoid effects of waning insulin action and plasma glucose was clamped at either 5 mmol/L (euglycemic control) or at 3.1 mmol/L (hypoglycemic) periods of 120 minutes. Baseline (clamp 1) and postexperiment (clamp 2) periods were assessed for net glucose disposal (as a function of the exogenous glucose infusion rate) and glucose kinetics using 3H-glucose. In normal subjects, glucose disposal increased progressively by 132{\%} during control studies but only by 57{\%} with intervening hypoglycemia (P < .005). Similarly, subjects with IDDM displayed marked reduction in glucose disposal following hypoglycemia (152{\%} increment during control v 33{\%} during hypoglycemia, P < .025). These changes were mediated by reduction of whole-body glucose uptake (rate of glucose disappearance [Rd], [3H]-3-glucose) and metabolic clearance rates with comparable suppression of hepatic glucose production in both groups. The increase in plasma free-fatty acids (FFA) following hypoglycemia was modest but greater in subjects with IDDM (P < .01), whereas IDDM had reduced concentrations of epinephrine (P < .01) and glucagon (P < .005) during hypoglycemia. In subjects with IDDM but not in normal subjects, the change in posthypoglycemia glucose disposal was inversely correlated with the increase in plasma norepinephrine (R2 = .54, P < .004) and epinephrine (R2 = .32, P < .04). Glucose disposal did not correlate with other counterregulatory hormones, plasma FFA, or antecedent glycemic control. The data suggest that posthypoglycemic insulin resistance develops immediately following mild hypoglycemia in humans. Impaired glucose disposal occurs in IDDM despite reduced epinephrine secretory responses and correlates with parameters of neuroadrenergic function.",
author = "Davis, {Maris R.} and Harry Shamoon",
year = "1992",
doi = "10.1016/0026-0495(92)90156-5",
language = "English (US)",
volume = "41",
pages = "216--223",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans

AU - Davis, Maris R.

AU - Shamoon, Harry

PY - 1992

Y1 - 1992

N2 - Insulin-mediated glucose disposal was studied immediately prior to and following moderate hypoglycemia in nondiabetic subjects and subjects with insulin-dependent (type I) diabetes mellitus (IDDM), the latter having varying epinephrine secretory capacities. Plasma insulin concentration was fixed throughout the study at ∼300 to 400 pmol/L to avoid effects of waning insulin action and plasma glucose was clamped at either 5 mmol/L (euglycemic control) or at 3.1 mmol/L (hypoglycemic) periods of 120 minutes. Baseline (clamp 1) and postexperiment (clamp 2) periods were assessed for net glucose disposal (as a function of the exogenous glucose infusion rate) and glucose kinetics using 3H-glucose. In normal subjects, glucose disposal increased progressively by 132% during control studies but only by 57% with intervening hypoglycemia (P < .005). Similarly, subjects with IDDM displayed marked reduction in glucose disposal following hypoglycemia (152% increment during control v 33% during hypoglycemia, P < .025). These changes were mediated by reduction of whole-body glucose uptake (rate of glucose disappearance [Rd], [3H]-3-glucose) and metabolic clearance rates with comparable suppression of hepatic glucose production in both groups. The increase in plasma free-fatty acids (FFA) following hypoglycemia was modest but greater in subjects with IDDM (P < .01), whereas IDDM had reduced concentrations of epinephrine (P < .01) and glucagon (P < .005) during hypoglycemia. In subjects with IDDM but not in normal subjects, the change in posthypoglycemia glucose disposal was inversely correlated with the increase in plasma norepinephrine (R2 = .54, P < .004) and epinephrine (R2 = .32, P < .04). Glucose disposal did not correlate with other counterregulatory hormones, plasma FFA, or antecedent glycemic control. The data suggest that posthypoglycemic insulin resistance develops immediately following mild hypoglycemia in humans. Impaired glucose disposal occurs in IDDM despite reduced epinephrine secretory responses and correlates with parameters of neuroadrenergic function.

AB - Insulin-mediated glucose disposal was studied immediately prior to and following moderate hypoglycemia in nondiabetic subjects and subjects with insulin-dependent (type I) diabetes mellitus (IDDM), the latter having varying epinephrine secretory capacities. Plasma insulin concentration was fixed throughout the study at ∼300 to 400 pmol/L to avoid effects of waning insulin action and plasma glucose was clamped at either 5 mmol/L (euglycemic control) or at 3.1 mmol/L (hypoglycemic) periods of 120 minutes. Baseline (clamp 1) and postexperiment (clamp 2) periods were assessed for net glucose disposal (as a function of the exogenous glucose infusion rate) and glucose kinetics using 3H-glucose. In normal subjects, glucose disposal increased progressively by 132% during control studies but only by 57% with intervening hypoglycemia (P < .005). Similarly, subjects with IDDM displayed marked reduction in glucose disposal following hypoglycemia (152% increment during control v 33% during hypoglycemia, P < .025). These changes were mediated by reduction of whole-body glucose uptake (rate of glucose disappearance [Rd], [3H]-3-glucose) and metabolic clearance rates with comparable suppression of hepatic glucose production in both groups. The increase in plasma free-fatty acids (FFA) following hypoglycemia was modest but greater in subjects with IDDM (P < .01), whereas IDDM had reduced concentrations of epinephrine (P < .01) and glucagon (P < .005) during hypoglycemia. In subjects with IDDM but not in normal subjects, the change in posthypoglycemia glucose disposal was inversely correlated with the increase in plasma norepinephrine (R2 = .54, P < .004) and epinephrine (R2 = .32, P < .04). Glucose disposal did not correlate with other counterregulatory hormones, plasma FFA, or antecedent glycemic control. The data suggest that posthypoglycemic insulin resistance develops immediately following mild hypoglycemia in humans. Impaired glucose disposal occurs in IDDM despite reduced epinephrine secretory responses and correlates with parameters of neuroadrenergic function.

UR - http://www.scopus.com/inward/record.url?scp=0026575213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026575213&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(92)90156-5

DO - 10.1016/0026-0495(92)90156-5

M3 - Article

VL - 41

SP - 216

EP - 223

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 2

ER -